“Anatomical and visual outcome of intravitreal bevacizumab (Avastin) in patients with diabetic macular edema”, Nep J Oph, vol. 8, no. 1, pp. 54–61, Dec. 2016, doi: 10.3126/nepjoph.v8i1.16157.